Stock Analysis

Elmera Group Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

OB:ELMRA
Source: Shutterstock

Elmera Group (OB:ELMRA) Second Quarter 2024 Results

Key Financial Results

  • Revenue: kr2.11b (down 40% from 2Q 2023).
  • Net income: kr37.1m (up 292% from 2Q 2023).
  • Profit margin: 1.8% (up from 0.3% in 2Q 2023). The increase in margin was driven by lower expenses.
  • EPS: kr0.34 (up from kr0.087 in 2Q 2023).
earnings-and-revenue-growth
OB:ELMRA Earnings and Revenue Growth August 16th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Elmera Group EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 15%. Earnings per share (EPS) exceeded analyst estimates by 43%.

Looking ahead, revenue is expected to decline by 1.4% p.a. on average during the next 3 years, while revenues in the Electric Utilities industry in Europe are expected to grow by 1.2%.

Performance of the market in Norway.

The company's shares are up 1.3% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 2 warning signs for Elmera Group you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Elmera Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.